CN108872606B - 一种高度稳定、灵敏的结合珠蛋白(hp)检测试剂盒 - Google Patents
一种高度稳定、灵敏的结合珠蛋白(hp)检测试剂盒 Download PDFInfo
- Publication number
- CN108872606B CN108872606B CN201810922651.4A CN201810922651A CN108872606B CN 108872606 B CN108872606 B CN 108872606B CN 201810922651 A CN201810922651 A CN 201810922651A CN 108872606 B CN108872606 B CN 108872606B
- Authority
- CN
- China
- Prior art keywords
- reagent
- haptoglobin
- detection kit
- sensitive
- highly stable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 102000014702 Haptoglobin Human genes 0.000 title claims abstract description 93
- 108050005077 Haptoglobin Proteins 0.000 title claims abstract description 93
- 238000001514 detection method Methods 0.000 title claims abstract description 46
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 84
- 239000004816 latex Substances 0.000 claims abstract description 29
- 229920000126 latex Polymers 0.000 claims abstract description 29
- 239000002245 particle Substances 0.000 claims abstract description 22
- 239000003755 preservative agent Substances 0.000 claims abstract description 16
- 230000002335 preservative effect Effects 0.000 claims abstract description 16
- 238000000034 method Methods 0.000 claims abstract description 10
- 239000007853 buffer solution Substances 0.000 claims abstract description 9
- 241000283707 Capra Species 0.000 claims abstract description 8
- XNPKNHHFCKSMRV-UHFFFAOYSA-N 4-(cyclohexylamino)butane-1-sulfonic acid Chemical group OS(=O)(=O)CCCCNC1CCCCC1 XNPKNHHFCKSMRV-UHFFFAOYSA-N 0.000 claims description 28
- 239000000872 buffer Substances 0.000 claims description 16
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 claims description 4
- 239000004793 Polystyrene Substances 0.000 claims description 2
- 230000021523 carboxylation Effects 0.000 claims description 2
- 238000006473 carboxylation reaction Methods 0.000 claims description 2
- GKJMOBYTOXEHKJ-UHFFFAOYSA-N dihydroxymethylurea Chemical compound NC(=O)NC(O)O GKJMOBYTOXEHKJ-UHFFFAOYSA-N 0.000 claims description 2
- 238000003366 endpoint assay Methods 0.000 claims description 2
- 229920002223 polystyrene Polymers 0.000 claims description 2
- 239000002244 precipitate Substances 0.000 claims description 2
- 238000003756 stirring Methods 0.000 claims description 2
- 239000001384 succinic acid Substances 0.000 claims description 2
- 239000006228 supernatant Substances 0.000 claims description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 abstract description 19
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 abstract description 19
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 abstract description 19
- 239000000845 maltitol Substances 0.000 abstract description 19
- 229940035436 maltitol Drugs 0.000 abstract description 19
- 235000010449 maltitol Nutrition 0.000 abstract description 19
- ODLHGICHYURWBS-LKONHMLTSA-N trappsol cyclo Chemical compound CC(O)COC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)COCC(O)C)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1COCC(C)O ODLHGICHYURWBS-LKONHMLTSA-N 0.000 abstract description 19
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 abstract description 16
- 229920002594 Polyethylene Glycol 8000 Polymers 0.000 abstract description 12
- 230000035945 sensitivity Effects 0.000 abstract description 11
- 125000001453 quaternary ammonium group Chemical group 0.000 abstract description 8
- KIWBPDUYBMNFTB-UHFFFAOYSA-N Ethyl hydrogen sulfate Chemical compound CCOS(O)(=O)=O KIWBPDUYBMNFTB-UHFFFAOYSA-N 0.000 abstract description 4
- 238000002360 preparation method Methods 0.000 abstract description 3
- 238000000338 in vitro Methods 0.000 abstract description 2
- 238000011896 sensitive detection Methods 0.000 abstract 1
- 230000000052 comparative effect Effects 0.000 description 18
- 238000012360 testing method Methods 0.000 description 16
- 238000003908 quality control method Methods 0.000 description 10
- 239000000126 substance Substances 0.000 description 8
- 241001494479 Pecora Species 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- 239000003381 stabilizer Substances 0.000 description 6
- 239000004094 surface-active agent Substances 0.000 description 6
- 102000018146 globin Human genes 0.000 description 5
- 108060003196 globin Proteins 0.000 description 5
- 210000002966 serum Anatomy 0.000 description 5
- 238000003556 assay Methods 0.000 description 4
- 206010012601 diabetes mellitus Diseases 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 3
- 230000015556 catabolic process Effects 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 238000006731 degradation reaction Methods 0.000 description 3
- 229940088597 hormone Drugs 0.000 description 3
- 239000005556 hormone Substances 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 238000002965 ELISA Methods 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 238000003018 immunoassay Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000004393 prognosis Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 206010048998 Acute phase reaction Diseases 0.000 description 1
- 206010051055 Deep vein thrombosis Diseases 0.000 description 1
- 206010061818 Disease progression Diseases 0.000 description 1
- 102000008857 Ferritin Human genes 0.000 description 1
- 108050000784 Ferritin Proteins 0.000 description 1
- 238000008416 Ferritin Methods 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000010378 Pulmonary Embolism Diseases 0.000 description 1
- 206010047249 Venous thrombosis Diseases 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000004658 acute-phase response Effects 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 230000009918 complex formation Effects 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 238000005536 corrosion prevention Methods 0.000 description 1
- 230000001054 cortical effect Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 230000005750 disease progression Effects 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 239000004005 microsphere Substances 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810922651.4A CN108872606B (zh) | 2018-08-14 | 2018-08-14 | 一种高度稳定、灵敏的结合珠蛋白(hp)检测试剂盒 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810922651.4A CN108872606B (zh) | 2018-08-14 | 2018-08-14 | 一种高度稳定、灵敏的结合珠蛋白(hp)检测试剂盒 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN108872606A CN108872606A (zh) | 2018-11-23 |
CN108872606B true CN108872606B (zh) | 2020-12-22 |
Family
ID=64319044
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810922651.4A Active CN108872606B (zh) | 2018-08-14 | 2018-08-14 | 一种高度稳定、灵敏的结合珠蛋白(hp)检测试剂盒 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108872606B (zh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111381040A (zh) * | 2018-12-27 | 2020-07-07 | 山东博科生物产业有限公司 | 一种性能高效的检测结合珠蛋白检测试剂 |
CN109725160B (zh) * | 2018-12-30 | 2021-03-23 | 山东博科生物产业有限公司 | 一种降钙素原(pct)检测试剂盒 |
CN113433317B (zh) * | 2021-06-23 | 2024-02-02 | 湖北民族大学附属民大医院 | 一种基质金属蛋白酶-3测定试剂盒及其制备方法 |
CN117368466B (zh) * | 2023-12-08 | 2024-03-12 | 安徽惠邦生物工程有限公司 | 用生化分析仪测定尿结合珠蛋白的试剂盒及其制备方法 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101305093A (zh) * | 2005-11-11 | 2008-11-12 | 东洋纺织株式会社 | 用于稳定生物分子的方法及组合物 |
CN102115737A (zh) * | 2009-12-31 | 2011-07-06 | 深圳迈瑞生物医疗电子股份有限公司 | 稳定碱性磷酸酶或其标记物的试剂和方法 |
CN104215770A (zh) * | 2014-08-14 | 2014-12-17 | 上海睿康生物科技有限公司 | 一种基于双粒子的视黄醇结合蛋白检测试剂盒 |
CN104535756A (zh) * | 2008-07-04 | 2015-04-22 | 积水医疗株式会社 | 免疫学测定的灵敏度增强方法或避免血红蛋白影响的方法 |
CN105334211A (zh) * | 2015-10-20 | 2016-02-17 | 北京中生金域诊断技术股份有限公司 | 一种同时检测尿液中钠和肌酐的试剂盒 |
CN106053839A (zh) * | 2016-07-12 | 2016-10-26 | 安徽伊普诺康生物技术股份有限公司 | 一种测定结合珠蛋白的试剂盒及其制备方法 |
-
2018
- 2018-08-14 CN CN201810922651.4A patent/CN108872606B/zh active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101305093A (zh) * | 2005-11-11 | 2008-11-12 | 东洋纺织株式会社 | 用于稳定生物分子的方法及组合物 |
CN104535756A (zh) * | 2008-07-04 | 2015-04-22 | 积水医疗株式会社 | 免疫学测定的灵敏度增强方法或避免血红蛋白影响的方法 |
CN102115737A (zh) * | 2009-12-31 | 2011-07-06 | 深圳迈瑞生物医疗电子股份有限公司 | 稳定碱性磷酸酶或其标记物的试剂和方法 |
CN104215770A (zh) * | 2014-08-14 | 2014-12-17 | 上海睿康生物科技有限公司 | 一种基于双粒子的视黄醇结合蛋白检测试剂盒 |
CN105334211A (zh) * | 2015-10-20 | 2016-02-17 | 北京中生金域诊断技术股份有限公司 | 一种同时检测尿液中钠和肌酐的试剂盒 |
CN106053839A (zh) * | 2016-07-12 | 2016-10-26 | 安徽伊普诺康生物技术股份有限公司 | 一种测定结合珠蛋白的试剂盒及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN108872606A (zh) | 2018-11-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108872606B (zh) | 一种高度稳定、灵敏的结合珠蛋白(hp)检测试剂盒 | |
CN106198415A (zh) | 一种测定糖化血红蛋白的试剂盒及其制备方法 | |
JPS6066996A (ja) | 血漿中のフイブリノゲン及びフイブリノゲン分解生成物を同時に測定する方法及び試薬 | |
CN112526134A (zh) | 一种壳多糖酶3样蛋白1测定试剂盒 | |
CN111239421A (zh) | 一种定量检测脂联素adpn的胶乳增强免疫比浊试剂盒及其制备与应用方法 | |
CN103852584A (zh) | 一种定量检测c肽的胶乳增强免疫比浊试剂盒 | |
CN102636653A (zh) | 复合胶乳粒子包被胱抑素c检测试剂盒 | |
CN105548560A (zh) | 血清白蛋白检测试剂和血清白蛋白检测方法 | |
CN108872607B (zh) | 一种α2-巨球蛋白(α2-MG)检测试剂盒 | |
CN110954693A (zh) | 一种肿瘤标志物Cyfra21-1的Simoa试剂盒及其应用 | |
CN109613280B (zh) | 一种血清铁测定试剂盒及其制备方法和应用 | |
CN101320041A (zh) | 一种快速定量检测c-反应蛋白的胶体金法及其应用 | |
CN112763725B (zh) | 一种胶乳比浊法测定c反蛋白检测试剂的制备及应用 | |
EP3923806B1 (en) | Calibrators and controls for the determination of the percentage of glycated hemoglobin in a patient's liquid test sample | |
CN116413431A (zh) | 一种改良型特异性生长因子检测试剂盒及其应用 | |
CN114295840B (zh) | 一种高灵敏度定量测定脂联素的试剂盒及其制备方法 | |
CN111579788A (zh) | 一种高灵敏肿瘤标志物EPHA2的Simoa试剂盒及其应用 | |
CN106443004A (zh) | 一种快速定量同时检测cTnI、H‑FABP的时间分辨荧光免疫层析试剂及制备方法 | |
CN114200129B (zh) | 组织金属蛋白酶抑制剂-2胶乳免疫比浊法血尿同检试剂盒 | |
CN106645694A (zh) | 一种纤维结合蛋白检测试剂盒 | |
Nechaeva et al. | Rapid Automatic Determination of Four Cardiomarkers in the Blood Plasma of Patients with Cardiopathologies | |
CN102721819B (zh) | 一种脂联素的竞争抑制性酶联免疫检测试剂盒及方法 | |
CN108445207B (zh) | 一种稳定、灵敏的胰岛素检测试剂 | |
CN117647644B (zh) | 一种封闭剂及其在免疫检测中的应用 | |
CN202404104U (zh) | 胱抑素c浓度检测试剂盒 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A highly stable and sensitive binding Globin (HP) detection kit Effective date of registration: 20230628 Granted publication date: 20201222 Pledgee: Bank of Communications Ltd. Shandong branch Pledgor: BIOBASE BIODUSTRY (SHANDONG) Co.,Ltd. Registration number: Y2023980045843 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Granted publication date: 20201222 Pledgee: Bank of Communications Ltd. Shandong branch Pledgor: BIOBASE BIODUSTRY (SHANDONG) Co.,Ltd. Registration number: Y2023980045843 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right |